NZ285593A - An enteral nutritional product containing casein that is sufficient to inhibit infection of mammalian cells by human rotavirus - Google Patents

An enteral nutritional product containing casein that is sufficient to inhibit infection of mammalian cells by human rotavirus

Info

Publication number
NZ285593A
NZ285593A NZ285593A NZ28559395A NZ285593A NZ 285593 A NZ285593 A NZ 285593A NZ 285593 A NZ285593 A NZ 285593A NZ 28559395 A NZ28559395 A NZ 28559395A NZ 285593 A NZ285593 A NZ 285593A
Authority
NZ
New Zealand
Prior art keywords
sufficient
mammalian cells
product containing
nutritional product
enteral nutritional
Prior art date
Application number
NZ285593A
Inventor
Pradip Mukerji
Pedro Antonio Prieto
Amanda Eug-Yeong Seo
Jeffrey Harris Baxter
Richard Dale Cummings
Original Assignee
Abbott Lab
Univ Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/308,883 external-priority patent/US5576300A/en
Application filed by Abbott Lab, Univ Oklahoma filed Critical Abbott Lab
Publication of NZ285593A publication Critical patent/NZ285593A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NZ285593A 1994-09-16 1995-05-05 An enteral nutritional product containing casein that is sufficient to inhibit infection of mammalian cells by human rotavirus NZ285593A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30888294A 1994-09-16 1994-09-16
US08/308,883 US5576300A (en) 1994-09-16 1994-09-16 Method for inhibition of human rotavirus infection
PCT/US1995/005676 WO1996008269A1 (en) 1994-09-16 1995-05-05 Inhibition of human rotavirus infection

Publications (1)

Publication Number Publication Date
NZ285593A true NZ285593A (en) 1999-03-29

Family

ID=26976500

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ285593A NZ285593A (en) 1994-09-16 1995-05-05 An enteral nutritional product containing casein that is sufficient to inhibit infection of mammalian cells by human rotavirus

Country Status (7)

Country Link
EP (1) EP0784479A1 (en)
JP (1) JPH10505828A (en)
AU (1) AU711437B2 (en)
CA (1) CA2199707A1 (en)
MX (1) MX9701979A (en)
NZ (1) NZ285593A (en)
WO (1) WO1996008269A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114837B2 (en) 2005-09-30 2012-02-14 Morinaga Milk Industry Co., Ltd. Method for inhibiting postprandial rise in blood glucose by administering κ-casein

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001516570A (en) * 1997-09-16 2001-10-02 ヴォルフ ゲオルグ フォースマン Bifidogenic peptides
EP1623717B1 (en) 2003-03-14 2018-08-29 Meiji Co., Ltd. Composition against rotavirus infection and process for producing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2631470B2 (en) * 1987-05-15 1997-07-16 雪印乳業株式会社 Infection protective agent
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JP2976349B2 (en) * 1990-11-29 1999-11-10 雪印乳業株式会社 Method for producing k-casein glycomacropeptide
DK8892D0 (en) * 1992-01-23 1992-01-23 Symbicom Ab HUMANT PROTEING
CA2148261A1 (en) * 1992-10-30 1994-05-11 Jerry A. Peterson Anti-diarrheic product and method of treating rotavirus-associated infection
DK2193D0 (en) * 1993-01-08 1993-01-08 Novo Nordisk As

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114837B2 (en) 2005-09-30 2012-02-14 Morinaga Milk Industry Co., Ltd. Method for inhibiting postprandial rise in blood glucose by administering κ-casein
US8367608B2 (en) 2005-09-30 2013-02-05 Morinaga Milk Industry Co., Ltd. Method for promoting secretion of glucagon-like peptide-1 by administering κ-casein

Also Published As

Publication number Publication date
EP0784479A1 (en) 1997-07-23
MX9701979A (en) 1997-06-28
WO1996008269A1 (en) 1996-03-21
AU2474495A (en) 1996-03-29
AU711437B2 (en) 1999-10-14
JPH10505828A (en) 1998-06-09
CA2199707A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
GB2146650B (en) Inclusion compound of eicosapentaenoic acid and food product containing the same
HUT44027A (en) Process for production of derivatives of phenil-piperisin with antiarithmical effect and medical compouns containing them
IL84303A0 (en) Preparation of highly pure cyclic esters
EP0195365A3 (en) Preparation of gelatinized foodstuffs
EP0346884A3 (en) Production process of kefir-like fermented milk
EP0265884A3 (en) Process relative to foods of animal origin
AU557264B2 (en) Lactic acid fermentation of sunflower seed milk
ZA885359B (en) Synthesis of crystalline silicophoshoaluminate
DE3661236D1 (en) Preparation of food product
GB8700354D0 (en) Culture of micro-organisms
GB8710780D0 (en) Opthalmological application of eicosapentaenoic acid
NZ285593A (en) An enteral nutritional product containing casein that is sufficient to inhibit infection of mammalian cells by human rotavirus
GB8801163D0 (en) Device permitting prolonged storage of nutrient products
HUT40112A (en) Process for production of derivatives of 2-/4,5-dihydro-1/1-imidasole-2-il/-2,3-dihydro-indol and medical preparatives containing thereof
GB8712127D0 (en) Synthesis of animal cries
ZA863218B (en) Novel anthelmintic fermentation products of microorganisms
AU3678689A (en) Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
GB9125052D0 (en) Culture of bone cells
IL88752A0 (en) Preparation of optically active cyano-hydrin derivatives and their conversion products and certain such novel optically active compounds
AP8900156A0 (en) Manufacture of fermented cereal product
JPS6461498A (en) Thymopoietin of human being
GB2113525B (en) Production of fermented milk products
AU3560984A (en) Adaption of microorganisms to produce l-serine
AU7865387A (en) Hydantoins as animal food supplements
IL84890A0 (en) Process of transforming bacterial cells

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)